Improved cutaneous melanoma survival stratification through integration of 31-gene expression profile testing with the American Joint Committee on Cancer 8th Edition Staging.

Saved in:
Bibliographic Details
Title: Improved cutaneous melanoma survival stratification through integration of 31-gene expression profile testing with the American Joint Committee on Cancer 8th Edition Staging.
Authors: Wisco OJ; Dermatology Health Specialists, Bend, Oregon., Marson JW; National Society for Cutaneous Medicine, New York, New York., Litchman GH; Department of Dermatology, St. John's Episcopal Hospital, Far Rockaway, New York., Brownstone N; National Society for Cutaneous Medicine, New York, New York., Covington KR; Research and Development, Castle Biosciences, Inc., Friendswood, Texas., Martin BJ; Research and Development, Castle Biosciences, Inc., Friendswood, Texas., Quick AP; Research and Development, Castle Biosciences, Inc., Friendswood, Texas., Siegel JJ; Research and Development, Castle Biosciences, Inc., Friendswood, Texas., Caruso HG; Research and Development, Castle Biosciences, Inc., Friendswood, Texas., Cook RW; Research and Development, Castle Biosciences, Inc., Friendswood, Texas., Winkelmann RR; OptumCare, Los Angeles, California., Rigel DS; Department of Dermatology, Mount Sinai Ichan School of Medicine, New York, New York, USA.
Source: Melanoma research [Melanoma Res] 2022 Apr 01; Vol. 32 (2), pp. 98-102.
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9109623 Publication Model: Print Cited Medium: Internet ISSN: 1473-5636 (Electronic) Linking ISSN: 09608931 NLM ISO Abbreviation: Melanoma Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1473-5636
DOI:10.1097/CMR.0000000000000804